TUMORVUE
Dead / Cancelled — Cancelled — Section 8 (as of 05 Jul 2024)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87248763
- Registration number
- 5358071
- Mark type
- Stylized text
- Filed
- 28 Nov 2016
- Published for opposition
- 03 Oct 2017
- Registered
- 19 Dec 2017
Goods and services
- Class 005 — Pharmaceuticals: Radiopharmaceutical and imaging and detection agent for diagnosing and monitoring diseases, namely, noninvasive agent for whole body targeting of treatment response for clinical applications for cancer and cardiovascular diseases
Owner
- Molecular Targeting Technologies, Inc., West Chester, PA, US
- Molecular Targeting Technologies, Inc., West Chester, PA, US
- Molecular Targeting Technologies, Inc., West Chester, PA, US
Prosecution history
- 05 Jul 2024 — CANCELLED SEC. 8 (6-YR)
- 19 Dec 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 19 Dec 2017 — REGISTERED-PRINCIPAL REGISTER
- 03 Oct 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Oct 2017 — PUBLISHED FOR OPPOSITION
- 13 Sept 2017 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Aug 2017 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Aug 2017 — PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
- 22 Aug 2017 — TEAS VOLUNTARY AMENDMENT RECEIVED
- 21 Jul 2017 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 21 Jul 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 16 Jul 2017 — ASSIGNED TO LIE
- 07 Jun 2017 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 09 Mar 2017 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 09 Mar 2017 — NON-FINAL ACTION E-MAILED